Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
His and her health donated $1 million to the president-elect Donald Trump’with inaugural fundconfirmed to CNBC on Tuesday.
The company, which offers a wide range of treatments for conditions such as weight loss, erectile dysfunction and hair loss, is the latest in a string of tech companies trying to curry favor with the new administration. OpenAI CEO Sam Altman and Meta both announced Donations of $1 million in the inaugural fund at the end of last year, and Amazon and an apple CEO Tim Cook also reportedly contributed.
“At Hims & Hers, we support leaders and advocates who are committed to improving America’s broken health care system,” the company said in a statement to CNBC.
Axios first reported the Hims & Hers donation.
Hims & Hers was a breakout star in the digital health sector last year, largely due to the success of a popular new weight loss offering.
The company began writing prescriptions complex semaglutide through its platform in May after launching a weight loss program in late 2023. Semaglutide is the active ingredient Nova Nordiskthe popular drugs Ozempic and Wegovy, which can cost about $1,000 a month without insurance. Combination semaglutide is a cheaper, custom-made alternative to brand-name drugs and can be made when brand-name treatments are available. deficit.
The future of mixed GLP-1s in the US is not entirely clear, especially as members of Trump’s entourage express conflicting views on the drug more broadly. Robert F. Kennedy JrTrump’s pick to head the Department of Health and Human Services criticized GLP-1. He told CNBC in an interview that the “first line of response” to obesity should be lifestyle changes, although he added that “GLP drugs have a place.”
Dr. Marty McCurry, Trump’s pick to head the Food and Drug Administration, served as CEO of Sesame, a telehealth company that connects consumers with doctors who can prescribe GLP-1 drugs. In recent years, however, Macario’s role on Sesame has been largely ceremonial.
Elon Musk, Tesla The CEO, who has been a close Trump confidant since the election, has been outspoken in his support for the drug.
“Nothing will improve the health, length and quality of life of Americans more than making GLP inhibitors super cheap for the public,” Musk wrote in post on its social media platform X in December.
At an event with reporters in New York late last year attended by CNBC, Hims & Hers said it would work with the incoming administration and shared the company’s view on the value of drugs.
